Philanthropy & Grantmaking
(T70Z)
IRS Verified
DX Registered
990 on File
ENTERTAINMENT INDUSTRY FOUNDATION
Financial strength (30%)
78/100
Reliability (20%)
55/100
Effectiveness (25%)
88/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
Stand Up To Cancer’s (SU2C) mission is to raise funds to accelerate the pace of groundbreaking translational research that can get new therapies to patients quickly and save lives now. SU2C brings together the best and the brightest researchers and mandates collaboration among the cancer community. By galvanizing the entertainment industry, SU2C has set out to generate awareness, educate the public on cancer prevention and help more people diagnosed with cancer become long-term survivors.
Financial Overview — FY 2024
$72.9M
Total Revenue
$86.4M
Total Expenses
$73.0M
Net Assets
106
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
84.2%
Fundraising Efficiency
N/A
Operating Reserve
10.13x
Liability-to-Asset
13.7%
Revenue Diversification
97.6%
Executive Compensation
$2.2M
Compared with Peers
FY 2024
Compared with 923 similar organizations
(United States, Philanthropy & Grantmaking, $10M–$100M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
84.2% | 91.7% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
8.9% | 6.2% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
6.9% | 2.2% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
10.1 mo | 69.8 mo |
P10P90
|
Bottom quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
13.7% | 2.5% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
97.6% | 88.2% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
-28.8% | 17.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-18.0% | 10.6% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-18.5% | 6.3% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $72.9M | $86.4M | $73.0M | 84.2% | 106 |
| 2023 | $102.4M | $105.4M | $86.3M | 84.6% | 111 |
| 2022 | $57.8M | $59.3M | $88.0M | 78.7% | 98 |
| 2021 | $128.5M | $64.7M | N/A | — | 98 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.